SENSEX NIFTY

Drug Company

Jul 22, 2014 at 09:35 | Source: Moneycontrol.com
The US Food and Drug Administration (US FDA) has approved the sterile facility (plant-II) and solid dosage facility (plant -III) located at Verna in the adjoining coastal state, a company release said.
Jul 21, 2014 at 22:18 | Source: PTI
The US Food and Drug Administration (US FDA) has approved the sterile facility (plant-II) and solid dosage facility (plant -III) located at Verna in the adjoining coastal state, a company release said.
Jul 21, 2014 at 08:51 | Source: Moneycontrol.com
Trimurthi Drugs & Pharmaceuticals has informed that a meeting of the Board of Directors of the Company will be held on July 30, 2014, to review the performance of the Company and to Consider, approve and take on record the unaudited financial results for the quarter ended June 30, 2014.
Jul 19, 2014 at 16:08 | Source: Moneycontrol.com
Last week the Bombay High Court upheld the compulsory license granted to Indian pharma company Natco for the sale of a generic version of Bayer's anti-cancer drug Nexavar. Here's a look back at the first legal challenge against a compulsory license in India.
Jul 18, 2014 at 20:29 | Source: Moneycontrol.com
Mangalam Drugs & Organics has informed that the Registered office of the Company will be shifting to 3rd Floor, Rupam Building, 237, P. D. Mello Road, Mumbai - 400001, MAHARASHTRA with effect from the July 21, 2014.
Jul 17, 2014 at 12:28 | Source: Moneycontrol.com
Aarey Drugs & Pharmaceuticals Ltd has informed BSE that the Board of Directors of the Company at its meeting held on July 17, 2014, has approved to avail a cash credit (hyp. of stocks & Book Debts) of Rs. 14.50 crores from Dena Bank.
Jul 16, 2014 at 19:54 | Source: CNBC-TV18
Sources suggest drug company chiefs have already started making their visits to Delhi. At least 3-4 have already sought meetings in the ministry to put forth their concerns as a lot of fresh questions are arising as they read deeper into the order.
Jul 16, 2014 at 09:01 | Source: Moneycontrol.com
Natco is pleased to inform that the Bombay High Court upheld the compulsory license (CL) granted to the Company on Nexavar (sorafenib tosylate) of German drug Major Bayers patented kidney cancer drug.
Jul 14, 2014 at 09:08 | Source: CNBC-TV18
In an interview to CNBC-TV18, S Ramesh of Lupin said the National Pharmaceutical Pricing Authority, or NPPA, adding more drugs to price control is a retrograde step. He further added that itll be negative for the company, but couldn't quantify the financial impact.
Jul 12, 2014 at 11:34 | Source: Moneycontrol.com
Venmax Drugs and Pharmaceuticals Ltd has informed BSE that the Company is shifting its registered office to Shed No. 22, Plot No. 84, Phase - 1, IDA Cheriapally, Hyderabad - 500 051.
Messages on Drug Company »

sikandar

Gold Member

10 Followers

Dr Reddys Labs  

The US market continues to drive growth for Dr Reddy`s and other Indian generic drug companies. What if this paradigm changes in the global context? The US drives the growth but we have to diversify our sources of growth even though the relative importance of the US may not change. Emerging markets

8.53 PM Jun 30th

anil patil

Platinum Member

25 Followers

Aurobindo Pharm  

deal details with the stock exchanges showed. Morgan Stanley Asia Singapore, which is a shareholder of Aurobindo Pharma, sold 17,32,500 shares of the drug company for about Rs 670 apiece, valuing the transaction at Rs 116 crore. Morgan Stanley Asia Singapore held 46.16 lakh shares of Aurobindo Pharma

11.48 AM May 31st

superwoman

Platinum Member

27 Followers

Dishman Pharma  

Dishman Pharma is likely to move to UC after 28.05.2014. This drug company will find support at Rs.125/- on account of excellent results. Your best time to pick up this stock at the bottom fishing zone.

8.43 PM May 26th

shakira9

New Member

2 Followers

Legal  

Drug Policy Control Order (DPCO) put a cap on the prices of 348 essential drugs, is likely to impact domestic revenue generation of both homegrown and multinational drug companies in 2014

12.55 PM May 15th

Raj_2009

Platinum Member

32 Followers

GlaxoSmithKline  

, according to data tracker Dealogic. Many drug companies have paid down debt taken on during a buying spree in the earlier 2000s and are now generating lots of cash they want to put to work. Prescription drug makers are also attracted to acquisitions because deals can allow them cut costs and scale back

4.02 PM Apr 22nd

OrthoDoc

New Member

12 Followers

Aurobindo Pharm  

...so buy , rather accumulate Auro even at current levels for a 1-2 year timeframe. these US legalities are nothing new to Indian drug companies,happens all the time !

10.06 AM Apr 17th

Web Messenger

Platinum Member

228731 Followers

Sun Pharma  

Source:VC Circle - Sun Pharmaceutical Industries Ltd, the country's top drugmaker by market cap, is acquiring Ranbaxy Laboratories Ltd in an all-stock transaction, creating the world's fifth-largest generics drug company and the largest pharma company in India by far

12.10 PM Apr 8th

tubes

Platinum Member

62 Followers

Sun Pharma  

Is it patent dispute with Drug company UCB?

9.16 PM Mar 18th

bhagyodayat
rust

Gold Member

8 Followers

Vivimed Labs  

I am doctor by profession and knows the value of research and upcoming drugs. COMPANY has spent lot of rs in research and next quarter filing new ADNA / molecules which will drive the earning. you see almost 90% of shares are by institutes or large investor.

12.47 PM Mar 18th

Web Messenger

Platinum Member

228731 Followers

Cipla  

Source:Calcutta Telegraph News - Mumbai, Feb. 20: Cipla has entered into an agreement with MSD to market the latter’s anti-HIV drug raltegravir in the country. This is the first time that Cipla is entering into a strategic partnership with a multinational drug company. MSD is the trade name

2.10 PM Feb 21st

News across the web »
Jul 07, 2014 at 02:15 | Source: FirstPost
Jul 03, 2014 at 01:31 | Source: FirstPost
Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.